Purpose Invasive pulmonary aspergillosis is increasingly reported in patients with influenza
admitted to the intensive care unit (ICU). Classification of patients with influenza-associated …

There are currently a number of licensed azole antifungal drugs; however; only 4 (namely,
fluconazole, itraconazole, posaconazole, and voriconazole) are used frequently in a clinical …

Introduction: The rising prevalence of obesity confronts clinicians with dosing problems in the
(extreme) overweight population. Obesity has a great impact on key organs that play a role …

The European Society for Clinical Microbiology and Infectious Diseases, the European
Confederation of Medical Mycology and the European Respiratory Society Joint Clinical …

Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU). …

There is increasing concern that patients with coronavirus disease 2019 (COVID-19) might
be at risk of developing invasive pulmonary aspergillosis co-infection. 1 In a cohort of 221 …

Importance Results of studies on use of prophylactic haloperidol in critically ill adults are
inconclusive, especially in patients at high risk of delirium. Objective To determine whether …

We performed an observational study to investigate intensive care unit incidence, risk factors,
and outcomes of coronavirus disease–associated pulmonary aspergillosis (CAPA). We …

Posaconazole is typically used for preventing invasive yeast and mold infections such as
invasive aspergillosis in high-risk immunocompromised patients. The oral suspension was the …

Invasive pulmonary aspergillosis is emerging as a secondary infection in patients with
COVID-19, which can present as alveolar disease, airway disease (ie, invasive Aspergillus …